Scahill, C.M.* ; Digby, Z.* ; Sealy, I.M.* ; Wojciechowska, S.* ; White, R.J.* ; Collins, J.E.* ; Stemple, D.L.* ; Bartke, T. ; Mathers, M.E.* ; Patton, E.E.* ; Busch-Nentwich, E.M.*
Loss of the chromatin modifier Kdm2aa causes BrafV-600E -independent spontaneous melanoma in zebrafish.
PLoS Genet. 13:e1006959 (2017)
KDM2A is a histone demethylase associated with transcriptional silencing, however very little is known about its in vivo role in development and disease. Here we demonstrate that loss of the orthologue kdm2aa in zebrafish causes widespread transcriptional disruption and leads to spontaneous melanomas at a high frequency. Fish homozygous for two independent premature stop codon alleles show reduced growth and survival, a strong male sex bias, and homozygous females exhibit a progressive oogenesis defect. kdm2aa mutant fish also develop melanomas from early adulthood onwards which are independent from mutations in braf and other common oncogenes and tumour suppressors as revealed by deep whole exome sequencing. In addition to effects on translation and DNA replication gene expression, high-replicate RNA-seq in morphologically normal individuals demonstrates a stable regulatory response of epigenetic modifiers and the specific de-repression of a group of zinc finger genes residing in constitutive heterochromatin. Together our data reveal a complex role for Kdm2aa in regulating normal mRNA levels and carcinogenesis. These findings establish kdm2aa mutants as the first single gene knockout model of melanoma biology.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Histone Demethylase Kdm2a; Metastatic Melanoma; Gene-expression; Repair Pathway; Danio-rerio; Rna-seq; Cancer; Genome; Progression; Resistance
Keywords plus
Language
english
Publication Year
2017
Prepublished in Year
HGF-reported in Year
2017
ISSN (print) / ISBN
1553-7390
e-ISSN
1553-7404
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 13,
Issue: 8,
Pages: ,
Article Number: e1006959
Supplement: ,
Series
Publisher
Public Library of Science (PLoS)
Publishing Place
San Francisco
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502800-001
Grants
Copyright
Erfassungsdatum
2017-09-22